Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020637 · ClinicalTrials.gov registry record
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
A clinical trial of Critical Illness and Shock, sponsored by University of Nevada, Las Vegas.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07020637: Recruiting study of Critical Illness and Shock, sponsored by University of Nevada, Las Vegas.
NCT07020637 is a study of Critical Illness and Shock that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 100 participants, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07020637, a study of Critical Illness and Shock, is actively recruiting participants, sponsored by University of Nevada, Las Vegas.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.
Primary Outcome
Pearson correlation coefficient between stroke volume measurements obtained using transthoracic echocardiography and those obtained using bioreactance-based monitoring (Cheetah NICOM) in response to passive leg raising.
Conditions Studied
Interventions
- DEVICE Cheetah NICOM
Study Locations (1)
Nevada
- University Medical Center Southern Nevada - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-19 |
| Est. Completion | 2026-09-01 |
What NCT07020637 shows while recruiting
NCT07020637 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Cheetah NICOM is the first listed.
NCT07020637 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT07020637 about?
NCT07020637 is a clinical study titled "Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance". This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.
What is the current status of trial NCT07020637?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-10-19. Estimated completion is 2026-09-01.
What conditions does trial NCT07020637 study?
This clinical trial studies the following conditions: Critical Illness, Shock.
What interventions are being tested in trial NCT07020637?
The interventions under investigation include: Cheetah NICOM (DEVICE).
Who is sponsoring clinical trial NCT07020637?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07020637 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07020637's enrollment target sits among peer trials
100 63rd of 91 higher than 24 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial
RECRUITING · Phase 1
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
-
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI